Pancreatic Cancer Research

ResearcherThe Cancer Institute HospitalActive in the last 2 years

Yoshihiro Ono

Matched on OpenAlex author ID A5100828880. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 3 papers

Papers 7

  1. Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal comparative study. Co-author DOI 10.1093/bjsopen/zraf026↗
  2. Resectable Pancreatic Cancer with CA19-9 > 500 U/mL: A Biological Indicator for Survival Benefit with Intensive Neoadjuvant Chemotherapy. Co-author DOI 10.1245/s10434-025-17407-5↗
  3. ASO Author Reflections: Optimizing Treatment for Resectable Pancreatic Cancer: CA19-9 > 500 U/mL as a Biologic Indicator for Neoadjuvant Therapy. Co-author DOI 10.1245/s10434-025-17458-8↗
  4. Unique Biology of Pancreatic Ductal Adenocarcinoma Accompanied by Rapidly Impaired Diabetes: A Favorable Long-Term Survival Following Curative Resection. First author DOI 10.1245/s10434-023-14408-0↗
  5. New approach of circumferential lymph node dissection around the superior mesenteric artery for pancreatic cancer during pancreaticoduodenectomy (with video). Co-author DOI 10.1007/s00423-023-03159-x↗
  6. Impact of sarcopenia on S1 adjuvant chemotherapy and prognosis in pancreatic cancer patients. Co-author DOI 10.5582/bst.2023.01209↗
  7. KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer. Co-author DOI 10.1111/cas.15398↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yosuke Inoue · 7 shared papers, 2022–2025 · strength 1.36
  2. Atsushi Oba · 6 shared papers, 2023–2025 · strength 1.25
  3. Hiromichi Ito · 6 shared papers, 2023–2025 · strength 1.25
  4. Yu Takahashi · 5 shared papers, 2022–2025 · strength 0.89
  5. Aya Maekawa · 3 shared papers, 2025 · strength 0.68
  6. Takafumi Mie · 3 shared papers, 2025 · strength 0.68
  7. Kojiro Omiya · 3 shared papers, 2025 · strength 0.68
  8. Naoki Sasahira · 3 shared papers, 2022–2025 · strength 0.54
  9. Manabu Takamatsu · 3 shared papers, 2022–2024 · strength 0.50
  10. Yu Takahashi · 2 shared papers, 2025 · strength 0.47
  11. Masato Ozaka · 2 shared papers, 2025 · strength 0.43
  12. Akio Saiura · 2 shared papers, 2023–2024 · strength 0.39
  13. Tomotaka Kato · 2 shared papers, 2022–2023 · strength 0.30
  14. Yuki Hirose · 1 shared paper, 2025 · strength 0.21
  15. Toshifumi Wakai · 1 shared paper, 2025 · strength 0.21
  16. Sho Kiritani · 1 shared paper, 2024 · strength 0.20
  17. Kumi Takagi · 1 shared paper, 2023 · strength 0.18
  18. Kiyoshi Hasegawa · 1 shared paper, 2022 · strength 0.11
  19. Tsuyoshi Takeda · 1 shared paper, 2022 · strength 0.11
  20. Tatsunori Suzuki · 1 shared paper, 2022 · strength 0.11
  21. Tsuyoshi Hamada · 1 shared paper, 2022 · strength 0.11
  22. Minoru Kitago · 1 shared paper, 2022 · strength 0.11
  23. Yohei Masugi · 1 shared paper, 2022 · strength 0.11
  24. Yutaka Nakano · 1 shared paper, 2022 · strength 0.11
  25. Michiie Sakamoto · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.